Skip to main content
Medacta Group SA logo

Medacta Group SA — Investor Relations & Filings

Ticker · MOVE ISIN · CH0468525222 LEI · 506700P2PFU3A3DROC14 SW Manufacturing
Open in API
Filings indexed 197 across all filing types
Latest filing 2025-03-24 Annual Report
Country CH Switzerland
Listing SW MOVE

About Medacta Group SA

https://www.medacta.com/

Medacta Group SA is a medical device company that designs, manufactures, and distributes orthopaedic and neurosurgical products worldwide. Its portfolio focuses on joint replacement, spine surgery, and sports medicine. The company emphasizes innovation in minimally invasive surgical techniques and personalized patient solutions, developed through close collaboration with surgeons. A key component of its business model is the M.O.R.E. Institute, a global medical education platform that provides comprehensive training and support for healthcare professionals. Medacta is recognized for pioneering advanced surgical approaches, such as Kinematic Alignment for total knee replacement, with a focus on improving patient outcomes and healthcare sustainability.

Recent filings

Filing Released Lang Actions
Annual Report 2024
Annual Report Classification · 1% confidence The document is explicitly titled 'ANNUAL REPORT 2024' and contains comprehensive sections including a Management Report, Corporate Governance Report, Remuneration Report, and full Financial Statements. It provides detailed financial performance, business highlights, and strategic outlook for the fiscal year 2024. It meets all criteria for an Annual Report (10-K equivalent for international entities). FY 2024
2025-03-24 English
Medacta Group SA acquires Parcus Medical to accelerate expansion in Sportsmed
M&A Activity Classification · 1% confidence The document is a press release dated March 7, 2025, announcing that Medacta Group SA has acquired Parcus Medical. This type of announcement, detailing a significant corporate transaction (acquisition), does not fit neatly into the specific financial reporting categories like 10-K, ER, or IR. It is a material corporate event announcement. Since there is no specific category for M&A announcements (TAR is for merger proposals/takeover bids, which is close but this is a completed acquisition announcement), and it is not a standard regulatory filing like a 10-K or a short announcement of a report (RPA/RNS), the most appropriate general category for significant corporate news that doesn't fit elsewhere is Regulatory Filings (RNS), as it is a general regulatory announcement. However, reviewing the definitions, 'M&A Activity (Code: TAR)' is defined as 'Announcements and documents related to merger proposals or takeover bids.' An acquisition announcement is fundamentally M&A activity. Given the context of financial filings, TAR is the most specific fit for an acquisition announcement, even if the definition leans slightly towards 'proposals' or 'bids'. It is a major corporate action announcement.
2025-03-08 English
Medacta Group SA acquires Parcus Medical to accelerate expansion in Sportsmed
M&A Activity Classification · 1% confidence The document is a press release dated March 7, 2025, announcing that Medacta Group SA has acquired Parcus Medical. This type of announcement, detailing a significant corporate transaction (acquisition), does not fit neatly into the specific financial reporting categories like 10-K, ER, or IR. It is a material corporate event announcement. Since there is no specific category for M&A announcements (TAR is for merger proposals/takeover bids, which is close but this is a completed acquisition announcement), and it is not a standard regulatory filing like a 10-K or a short announcement of a report (RPA/RNS), the most appropriate general category for significant corporate news that doesn't fit elsewhere is Regulatory Filings (RNS), as it is a general regulatory announcement. However, reviewing the definitions, 'M&A Activity (Code: TAR)' is defined as 'Announcements and documents related to merger proposals or takeover bids.' An acquisition announcement is fundamentally M&A activity. Given the context of financial filings, TAR is the most specific fit for an acquisition announcement, even if the definition leans slightly towards 'proposals' or 'bids'. It is a major corporate action announcement.
2025-03-07 English
Medacta Group SA acquires Parcus Medical to accelerate expansion in Sportsmed
M&A Activity Classification · 1% confidence The document is explicitly labeled as a "Press Release" and details a significant corporate action: the acquisition of Parcus Medical by Medacta Group SA. This type of announcement, concerning corporate strategy, M&A activity, and immediate business updates, is typically disseminated via press release. While it relates to M&A (TAR), it is a general corporate announcement rather than a formal regulatory filing like a 10-K or a specific shareholder vote document. Since the definitions do not explicitly cover a general 'Press Release' category, I must evaluate the closest fit. The acquisition itself falls under M&A Activity (TAR). However, the document structure and content strongly suggest a general corporate news announcement. Given the options, M&A Activity (TAR) is the most specific category describing the core event (acquisition). If TAR is too specific for a general press release, the fallback would be RNS (Regulatory Filings). Since the event is a definitive acquisition announcement, TAR is the most appropriate classification for the substance of the news.
2025-03-07 English
Medacta Group SA reports significant above-market revenue growth of 16.2% in constant currency in 2024
Earnings Release Classification · 1% confidence The document is titled 'Ad-hoc' and explicitly states it is a 'Release of an ad hoc announcement pursuant to Art. 53 LR'. It reports preliminary, unaudited revenue figures for the full year 2024 (FY 2024) and announces the date for the full 2024 results release (March 25, 2025). This structure—a brief, immediate announcement of key financial highlights (revenue growth) before the comprehensive report—is characteristic of an Earnings Release (ER). It is not the full Annual Report (10-K) or the comprehensive Interim Report (IR), but the initial release of results. FY 2024
2025-02-04 English
Medacta Group SA reports significant above-market revenue growth of 16.2% in constant currency in 2024
Earnings Release Classification · 1% confidence The document is explicitly titled as an 'Ad hoc announcement pursuant to Art. 53 LR' and is a 'Press Release – Ad-hoc announcement pursuant to Art. 53 LR'. It reports preliminary, unaudited revenue figures for the full year 2024 and announces the date for the full 2024 results release (March 25, 2025). This structure—releasing key preliminary financial highlights ahead of the official, comprehensive report—is characteristic of an Earnings Release (ER). It is not the comprehensive Annual Report (10-K) or the comprehensive Interim Report (IR), but the initial announcement of results. FY 2024
2025-02-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.